scholarly article | Q13442814 |
P50 | author | Chunkit Fung | Q91807094 |
Paul C Dinh | Q95822328 | ||
Darren R Feldman | Q56588360 | ||
Michael T Milano | Q90387310 | ||
Sophie D Fossa | Q91444278 | ||
Lois B. Travis | Q91794501 | ||
P2093 | author name string | Hongmei Yang | |
Patrick O Monahan | |||
Mohammad Abu Zaid | |||
P2860 | cites work | Second malignant neoplasms and cardiovascular disease following radiotherapy | Q26864522 |
Cancer treatment and survivorship statistics, 2012 | Q27020961 | ||
Projected cancer risks from computed tomographic scans performed in the United States in 2007 | Q28267626 | ||
Comparison of SEER Treatment Data With Medicare Claims | Q30779910 | ||
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data | Q31122446 | ||
Therapy-related malignancies following treatment of germ cell cancer | Q33793905 | ||
Testicular cancer survivorship: research strategies and recommendations | Q34039684 | ||
Increasing incidence of testicular cancer worldwide: a review | Q34534348 | ||
Increased stomach cancer risk following radiotherapy for testicular cancer | Q35677701 | ||
Outcomes in stage I testicular seminoma: a population-based study of 9193 patients | Q35780174 | ||
Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion | Q35832143 | ||
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations | Q36359653 | ||
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study | Q36560166 | ||
Mortality and incidence of second cancers following treatment for testicular cancer | Q36609806 | ||
A study of soft tissue sarcomas after childhood cancer in Britain | Q36611058 | ||
Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study. | Q36953566 | ||
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study | Q37227682 | ||
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma | Q37459549 | ||
Second malignant neoplasms: assessment and strategies for risk reduction | Q38046164 | ||
Testicular cancer--discoveries and updates | Q38269543 | ||
Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival | Q38656848 | ||
Increased pancreatic cancer risk following radiotherapy for testicular cancer | Q39419020 | ||
Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer | Q39452307 | ||
Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia | Q39962944 | ||
Surveillance and Radiation Therapy for Stage I Seminoma--Have We Learned From the Evidence? | Q40174962 | ||
Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study | Q40551817 | ||
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy | Q42384332 | ||
Cancer risk prediction models: a workshop on development, evaluation, and application | Q44065523 | ||
Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma | Q44968874 | ||
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance | Q45001991 | ||
Second cancers after testicular cancer diagnosed after 1980 in Sweden | Q46412460 | ||
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH | Q46610975 | ||
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). | Q52858240 | ||
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors | Q58411051 | ||
Treatment-Associated Leukemia Following Testicular Cancer | Q58411442 | ||
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party | Q67558802 | ||
Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer | Q73100643 | ||
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group | Q73181376 | ||
Surveillance in stage I testicular cancer | Q73404456 | ||
Testicular germ-cell cancer | Q73520726 | ||
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors | Q73944612 | ||
Radiotherapy for stage II testicular seminoma | Q74613874 | ||
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214) | Q83333663 | ||
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era | Q89496327 | ||
Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era | Q90664127 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P921 | main subject | testicular cancer | Q324464 |
P304 | page(s) | pkaa017 | |
P577 | publication date | 2020-03-17 | |
P1433 | published in | JNCI Cancer Spectrum | Q68836165 |
P1476 | title | Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors | |
P478 | volume | 4 |